rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2007-5-3
|
pubmed:abstractText |
The pharmacokinetic (PK) study of recombinant human factor IX (rFIX) has been done in patients with hemophilia B in areas other than Taiwan. However, wide patient-related variability in recovery is noted and there is no PK study of rFIX in Taiwanese patients with hemophilia B. The purpose of this study is to evaluate the PKs of the rFIX in Taiwanese patients with hemophilia B.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0929-6646
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
106
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
281-7
|
pubmed:meshHeading |
pubmed-meshheading:17475604-Adolescent,
pubmed-meshheading:17475604-Adult,
pubmed-meshheading:17475604-Area Under Curve,
pubmed-meshheading:17475604-Factor IX,
pubmed-meshheading:17475604-Female,
pubmed-meshheading:17475604-Hemophilia B,
pubmed-meshheading:17475604-Humans,
pubmed-meshheading:17475604-Male,
pubmed-meshheading:17475604-Middle Aged,
pubmed-meshheading:17475604-Recombinant Proteins,
pubmed-meshheading:17475604-Taiwan
|
pubmed:year |
2007
|
pubmed:articleTitle |
Pharmacokinetic study of recombinant human factor IX in previously treated patients with hemophilia B in Taiwan.
|
pubmed:affiliation |
Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.
|
pubmed:publicationType |
Journal Article
|